BALDINI, S.; RIGACCI, L.; CARRAI, V.; ALTERINI, R.; FJERZA, R.; BOSI, A. PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE. Mediterranean Journal of Hematology and Infectious Diseases, v. 4, n. 1, p. e2012044, 28 jun. 2012.